Skip to content
Open access

Proximity labeling reveals unique and shared proximal proteomes associated with pE3-Aβ and 6E10 amyloid pathology in human Alzheimer’s disease hippocampus

Oct 2026 · Acta Neuropathologica Communications · 0 citations

Abstract

Amyloid plaques are a hallmark neuropathological feature of Alzheimer's disease (AD), composed of insoluble amyloid beta (Aβ) peptides. Aβ undergoes post-translational modifications that alter its biophysical properties, aggregation kinetics, and neurotoxicity, creating a heterogeneous pool of species that differentially affect AD pathogenesis. Pyroglutamate-modified Aβ at glutamate position 3 (pE3-Aβ) is a particularly aggregation-prone and proteolytically resistant variant that preferentially accumulates within plaque cores, is implicated in early plaque seeding, and is a major target of emerging anti-amyloid immunotherapies. However, the molecular environment surrounding pE3-Aβ vs. 6E10-positive amyloid pathology in the human hippocampus remains incompletely defined. Here, we used Biotinylation by Antibody Recognition (BAR), an in-situ proximity labeling approach, to map and compare the proximal proteomes associated with pE3-Aβ and 6E10-positive amyloid pathology in formalin-fixed postmortem human hippocampal tissue from pathologically confirmed AD cases and cognitively normal (CN) controls. Differential proteomic analysis identified 48 significantly enriched proteins in AD pE3-Aβ captures, 28 in AD 6E10 captures, and 15 in CN 6E10 captures. Whereas no significant enrichment was detected in CN pE3-Aβ captures, supporting pE3-Aβ as a pathology-associated species. pE3-Aβ in AD demonstrated the largest variant-specific signature with 31 unique proteins; 6E10 had 11 unique proteins in AD and 14 unique proteins in CN; 16 proteins were shared between AD pE3-Aβ and AD 6E10, with PCSK1N shared across AD pE3-Aβ and AD/CN 6E10. Pathway enrichment analysis of proximal proteomes revealed broader biological disruptions linked to pE3-Aβ, including synaptogenesis signaling, clathrin-mediated endocytosis, mitochondrial division signaling, and neurotransmitter release. Shared pathways included SNARE signaling, glutamatergic receptor signaling, and netrin signaling. These findings demonstrate that pE3-Aβ is associated with an expanded, variant-specific proximal proteome in human AD hippocampus and may implicate intracellular trafficking, synaptic signaling, and mitochondrial pathways as network-level vulnerabilities relevant to pE3-Aβ pathology in AD. Comparison of CN and AD 6E10-positive amyloid further distinguished proximal protein networks associated with 6E10-positive Aβ in CN tissue vs. pathological deposition.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.